Horan Securities, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Horan Securities, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$1.44 - $3.98 $1,471 - $4,067	1,022 Added 150.29%	1,702 $3,000
Q4 2021 Feb 09, 2022	SELL	$4.99 - $7.46 $1,422 - $2,126	-285 Reduced 29.53%	680 $3,000
Q1 2021 May 14, 2021	BUY	$8.81 - $16.96 $2,510 - $4,833	285 Added 41.91%	965 $9,000
Q4 2020 Feb 05, 2021	SELL	$8.5 - $12.85 $850 - $1,285	-100 Reduced 12.82%	680 $6,000
Q3 2020 Nov 04, 2020	BUY	$9.57 - $27.05 $957 - $2,705	100 Added 14.71%	780 $9,000
Q2 2020 Aug 11, 2020	BUY	$7.14 - $31.69 $4,855 - $21,549	680 New	680 $18,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $511M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.